METTL15: A Drug Target / Disease Biomarker (G196074)

Target Name: METTL15

NCBI ID: G196074

METTL15

Other Name(s): Methyltransferase 5 domain-containing protein 1 | Probable methyltransferase-like protein 15 | MET15_HUMAN | Methyltransferase like 15 | methyltransferase 5 domain containing 1 | 12S rRNA m4C methyltransferase | 12S rRNA N4-methylcytidine (m4C) methyltransferase (isoform 1) | METT5D1 | METTL15 variant X7 | methyltransferase-like protein 15 | METTL15 variant 1 | Probable S-adenosyl-L-methionine-dependent methyltransferase METT5D1 | Methyltransferase like 15, transcript variant 1 | methyltransferase like 15 | 12S rRNA N4-methylcytidine (m4C) methyltransferase | Methyltransferase-like protein 15 | Methyltransferase 5 domain containing 1 | probable methyltransferase-like protein 15 | putative S-adenosyl-L-methionine-dependent methyltransferase METT5D1 | methyltransferase 5 domain-containing protein 1 | probable S-adenosyl-L-methionine-dependent methyltransferase METT5D1 | Methyltransferase like 15, transcript variant X7 | Putative S-adenosyl-L-methionine-dependent methyltransferase METT5D1

METTL15: A Drug Target / Disease Biomarker

METTL15 is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the metal transmembrane protein family, which includes proteins that are involved in the transport of metals across cell membranes.

One of the unique features of METTL15 is its ability to interact with a wide range of metals, including gold, silver, and arsenic. This makes it an attractive candidate as a drug target, as these metals are often associated with a variety of health problems, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, METTL15 has also been shown to be involved in a number of important biological processes. For example, it is involved in the regulation of cell signaling pathways that are involved in everything from cell growth and differentiation to inflammation and stress. It is also involved in the regulation of the immune system, which is important for protecting the body against infection and disease.

One of the challenges in studying METTL15 as a drug target is its complex structure. METTL15 is a transmembrane protein that spans the cell membrane and consists of multiple domains that are involved in its function. This makes it difficult to predict how a given drug will interact with the protein and what the resulting effects will be.

However, researchers are making progress in understanding the biology of METTL15 and its potential as a drug target. For example, studies have shown that METTL15 is involved in a number of important biological processes, including the regulation of cell signaling pathways and the regulation of the immune system. Additionally, researchers have identified potential drug targets that can interact with METTL15 and enhance its effects.

In conclusion, METTL15 is a protein that is expressed in various tissues throughout the body and is involved in a number of important biological processes. Its potential as a drug target has generated a lot of interest and research in recent years, and further studies are needed to fully understand its biology and its potential as a therapeutic agent.

Protein Name: Methyltransferase Like 15

Functions: N4-methylcytidine (m4C) methyltransferase responsible for the methylation of position C839 in mitochondrial 12S rRNA (PubMed:31665743, PubMed:32371392). Involved in the stabilization of 12S rRNA folding, therefore facilitating the assembly of the mitochondrial small ribosomal subunits (PubMed:31665743, PubMed:32371392)

The "METTL15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about METTL15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets